Managers
Northleaf Capital Partners (Northleaf) has raised an additional USD1 billion in capital from Canadian, US, European and Asian investors across its global private markets program, reflecting continued strong investor interest in private equity, private credit and infrastructure investments.
These recent commitments include capital raised for Northleaf’s mid-market infrastructure and private credit programs, as well as significant new commitments to mid-market private equity and secondaries custom mandates managed on behalf of two of Canada’s largest institutional investors. Building on the firm’s strong growth momentum, this new capital brings Northleaf’s private equity, private credit and infrastructure commitments raised to more than USD13
The Management Board of teh Warsaw Stock Exchange Group (GPW) has launched a project aimed at the possible establishment of a Corporate Venture Capital fund (CVC fund) in conjunction with other financial market institutions.
In this connection, GPW has published on its website a Request for Information (RFI) addressed to teams experienced in venture capital fund management.
“We are starting yet another project, aiming to open a CVC fund, an effective tool for investing or collaboration with fintechs which develop technologies for capital market participants. Innovation is the very foundation of our strategic objectives. I am positive that this
Clessidra SGR, a management company in the Italian private equity market, has expanded its business scope by entering the bank credits segment, with a specific focus on the Unlikely to Pay receivables.
Clessidra seized the opportunity to expand into this market with the launch of a new fund dedicated to institutional investors, the Clessidra Restructuring Fund.
The Clessidra Restructuring Fund (CRF) includes two compartments dedicated respectively to the credits component and the new finance component. The credits compartment features receivables sold by 10 banking and financial groups towards 14 Italian companies, which are currently undergoing a financial and industrial
Council Capital, a healthcare-focused private equity firm based in Nashville, and Baird Capital, the direct private investment arm of Baird based in Chicago, have sold their stakes in emids to New Mountain Capital.
Terms of the transaction have not been disclosed. Both firms initially invested in emids in 2013.
emids is a global provider of technology services and solutions for healthcare payers and providers. The company’s services include consulting, custom application development, and data solutions that support EHR application deployment and management, analytics, data integration and governance, software development and testing, and business intelligence. emids is headquartered in Nashville.
TFG Asset management, a diversified alternative asset manager that owns majority and minority private equity stakes in asset management companies, is broadening its structured credit investing business under Tetragon Credit Partners.
The business has evolved from a historic focus on primary CLO control equity to a broader series of offerings across the CLO capital structure. TFG Asset Management is part of Tetragon Financial Group Limited, a closed-ended investment company that is traded on Euronext in Amsterdam N.V. and on the Specialist Fund Segment of the main market of the London Stock Exchange.
The CLO investing business – historically called Tetragon
SS&C Technologies Holdings, is to acquire certain Algorithmics and related assets from IBM. Algorithmics provides leading risk analytic products and services for the financial services industry worldwide.
The addition of Algorithmics, which is expected to be completed in the fourth quarter, pending the completion of customary closing conditions, will extend SS&C’s risk analytics and regulatory offering.
The acquisition adds over 200 clients, 350 employees and offices in 25 countries. Client types include banks, broker dealers, asset managers, hedge and private equity funds and service providers. Algorithmics’ solutions deliver the risk analytics clients need to address the impact of business
If investors are losing faith in politics, fiscal policy and economic cycles, private equity is proving to be something in which they keep believing, as Elizabeth Pfeuti explains…
Almost a third of investors responding to Preqin’s report into alternatives in the first half of 2019 said private equity had exceeded expectations over the past 12 months. An additional 61 per cent said they were satisfied with the outcome of their holdings. Compare that with 46 per cent of hedge fund investors whose expectations have not been met, followed by 37 per cent of investors in natural resources claiming the same.
With
Aviva Investors, the global asset management business of Aviva PLC, has entered into a development agreement with Transport for London (TfL) to build a mixed-use retail and office building opposite Liverpool Street Elizabeth Line Station.
Subject to planning approval, the Eric Parry designed scheme will provide 175,000 sq ft of office and retail space over ground and ten upper floors. The deal builds on Aviva Investors’ ongoing development project with Crossrail at 101 Moorgate. Aviva Investors ongoing development at the western entrance at 101 Moorgate is complimented by the new Liverpool Street Station deal which will see development at the
CAPZA, a private investment platform focusing on small and midcaps, is co-arranging, with BNP Paribas Principle Investments and AXA IM, the unitranche refinancing of La Maison Bleue.
Founded in 2004, La Maison Bleue manages a network of over 280 collective nurseries in France and 60 in Europe (Switzerland, Luxembourg and the United Kingdom). La Maison Bleue is supported by its investors TowerBrook and Bpifrance who have had majority shares since 2016.
CAPZA, BNP Paribas Principle Investments and AXA IM have co-arranged a refinancing deal of EUR150 million. The aim of this deal is to allow for greater development and
Kaia Health, a digital therapeutics company, has secured USD8 million in a funding round led by Optum Ventures.
Kaia Health has developed a smartphone-based approach for managing a number of chronic conditions, with a focus on musculoskeletal disorders (MSK) such as chronic back pain. Optum Ventures’ investment will aid Kaia Health in addressing issues their users face including the rising costs of treating MSK-related conditions and the difficulty that patients have accessing necessary treatment.
“The investment from Optum Ventures will allow us to explore integration opportunities throughout the complete patient treatment journey,” says Konstantin Mehl, Founder and CEO of
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
